Submit Manuscript

Journal of Biological Sciences

Year: 2004 | Volume: 4 | Issue: 5 | Page No.: 609-612
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Research Article

Determination of the Binding Sites of Arsenic on Bovine Serum Albumin Using Warfarin (Site-I Specific Probe) and Diazepam (Site-II Specific Probe)

S.J. Uddin, J.A. Shilpi, G.M.M. Murshid, A.A. Rahman, M.M. Sarder and M.A. Alam

ABSTRACT

The binding of arsenic (As) on bovine serum albumin (BSA) was studied by equilibrium dialysis (ED) method using warfarin sodium (as site-I specific probe) and diazepam (as site-II specific probe) to determine the binding sites of arsenic to BSA. The data obtained showed that the free concentration of warfarin sodium increased very slowly by the addition of arsenic, while the free concentration of diazepam increased rapidly by the addition of arsenic. The free concentration of warfarin was 10.5% in absence of arsenic whereas this release was up to 20% when arsenic was added to BSA with an increasing concentration from 0.5x10-5 to 10x10-5M. The free concentration of diazepam was 11% in absence of arsenic whereas this release was up to 50% when arsenic was added to BSA with an increasing concentration from 0.5x10-5 to 10x10-5M. This site-specific probe displacement data implied that site-I (warfarin site) is low affinity site while site-II (diazepam site) is high affinity site of arsenic to the BSA.
PDF References Citation

How to cite this article

S.J. Uddin, J.A. Shilpi, G.M.M. Murshid, A.A. Rahman, M.M. Sarder and M.A. Alam, 2004. Determination of the Binding Sites of Arsenic on Bovine Serum Albumin Using Warfarin (Site-I Specific Probe) and Diazepam (Site-II Specific Probe). Journal of Biological Sciences, 4: 609-612.

DOI: 10.3923/jbs.2004.609.612

URL: https://scialert.net/abstract/?doi=jbs.2004.609.612

Search

REFERENCES

  1. Kragh-Hansen, U., 1981. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev., 33: 17-53.
    PubMed
  2. Meloun, B., L. Moravec and V. Kostka, 1975. Complete amino acid sequence of human serum albumin. FEBS Lett., 58: 134-137.
  3. Brown, J.R., 1976. Structural origins of mammalian albumin. Feb. Proc., 35: 591-591.
    PubMed
  4. Sudlow, G., D.J. Birkett and D.N. Wade, 1975. The characterization of two specific binding sites of human serum albumin. Mol. Pharmacol., 11: 824-832.
  5. Sudlow, G., D.J. Birkett and D.N. Wade, 1976. Further characterization of two specific binding sites of human serum albumin. Mol. Pharmacol., 12: 1052-1061.
    PubMedDirect Link
  6. Feshke, K.J., U. Schlafer, U. Wollert and W.E. Muller, 1979. A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin. Biochem. Biophys. Acta, 577: 346-359.
  7. Hansen, K.U., 1981. Effect of aliphatic fatty acid on the binding of phenol red to human serum alnbumin. J. Biochem., 195: 603-613.
  8. Nahar, Z., M.H. Rhaman and A. Hasnat, 1997. Interaction of nifedipine with BSA: Effect of metals. Bangladesh J. Physiol. Pharmacol., 13: 18-20.
  9. Koch-Wester, J. and E.M. Sellers, 1976. Binding of drugs to serum albumin. N. Engl. J. Med., 294: 311-311.
  10. Singlas, E., 1987. Determination of Protein Binding and its Characteristics: Protein Binding of Drug. 2nd Edn., Hoffmann La Roche and Co. Ltd., Basle, Switzerland, pp: 25-31.
  11. Feshke, K.J., U. Schlafer, U. Wollert and W.E. Muller, 1982. Characterization of an important binding area on human serum albumin including the high affinity binding sites for warfarin and azapropazone. Mol. Pharmacol., 21: 387-393.
  12. He, X.M. and D.C. Carter, 1992. Atomic structure and chemistry of human serum albumin. Nature, 358: 209-215.
    CrossRefDirect Link
  13. Rahman, M.H., 1993. Characterization of high affinity binding sites of non-steroidal anti-inflamatory with respect to site specific probes on human serum albumin. Ph.D. Thesis, Kumamoto University, Japan.
  14. Goodman, L. and A. Gilman, 1996. The Pharmacological Basis of Therapeutics. 9th Edn., McGraw-Hill, USA., pp: 925.
  15. Singlas, E., 1987. Protein Binding of Drug. Chapter 1. 2nd Edn., Hoffmann-La Roche, Basel, pp: 20-22.

Search

Related Articles

Leave a Comment

Your email address will not be published. Required fields are marked *